Master the Boards: USMLE Step 2 CK, Second Edition

Please note the following updates and corrections:

Page
152
235
329
359
489
507
514
515

517
520

521
529

ISBN 978160978760-8

Change
PCP Prophylaxis #2: Atovoquone to Atovaquone
Head: Hypercoaguable to Hypercoagulable
Table (central vs. nephrogenic DI), last row:
ADH level CDI: Low NDI: High
DM line 2: HbA1c <6.5% to HbA1c >6.5%
Line 2: adenexal to adnexal
Table (exceptions to SSRU use), row 1 specific alternative:
Use duloxetine since it is approved for both depression and neuropathy.
Last line (schizophrenia treatment): . . . aripiprazole, paliperidone, asenapine,
iloperidone, or lurasidone.
(1) Top bullet, lines 23: . . . haloperidol is still used but has more side effects,
so if given the choice pick the atypical.
(2) Next bullet, line 2: . . . treatment. Haloperidol is still used . . .
Treatment (panic disorder), bullet 2: . . . may benefit from benzodiazepines
such as alprazolam, clonazepam, or lorazepam. Begin with . . .
(1) Treatment (PTSD) bullet 1: First line treatment includes paroxetine and
sertraline. Prazosin is used for nightmares.
(2) Treatment (generalized anxiety disorder), bullet 2: Venlafaxine and
buspirone are also effective.
Table (antianxiety meds & specific indications), medication row 3:
Chlordiazepoxide, oxazepam, lorazepam
Line 2: . . . used to maintain alertness. Therapy can also include
methylphenidate and dextroamphetamine GHB at bedtime to induce
symptoms of narcolepsy and contain them at night.